Bank Julius Baer & Co
SRPT icon

Bank Julius Baer & Co’s Sarepta Therapeutics SRPT Stock Holding History

Bank Julius Baer & Co’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-170
Closed -$16.4K – 562
2023
Q4 		$16.4K Sell
170
-822
-83% -$78.9K ﹤0.01% 513
2023
Q3 		$120K Sell
992
-52
-5% -$5.88K ﹤0.01% 409
2023
Q2 		$120K Sell
1,044
-2,855
-73% -$368K ﹤0.01% 443
2023
Q1 		$537K Sell
3,899
-1,361
-26% -$177K ﹤0.01% 337
2022
Q4 		$682K Sell
5,260
-1,696
-24% -$197K ﹤0.01% 310
2022
Q3 		$769K Buy
6,956
+3,638
+110% +$367K 0.01% 289
2022
Q2 		$249K Sell
3,318
-3,502
-51% -$258K ﹤0.01% 391
2022
Q1 		$533K Sell
6,820
-4,217
-38% -$323K ﹤0.01% 342
2021
Q4 		$994K Buy
11,037
+7,601
+221% +$650K 0.01% 355
2021
Q3 		$318K Sell
3,436
-63
-2% -$4.85K ﹤0.01% 495
2021
Q2 		$272K Buy
+3,499
New +$265K ﹤0.01% 536
2021
Q1 		– Sell
-3,173
Closed -$541K – 890
2020
Q4 		$541K Buy
3,173
+553
+21% +$81.9K ﹤0.01% 439
2020
Q3 		$318K Buy
2,620
+720
+38% +$109K ﹤0.01% 450
2020
Q2 		$272K Buy
+1,900
New +$259K ﹤0.01% 426

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Bank Julius Baer & Co's SRPT Position: Q1 2024 in Review

Bank Julius Baer & Co sold out of Sarepta Therapeutics (SRPT) in Q1 2024, closing a stake of 170 shares — an estimated $16.4K sold.

Bank Julius Baer & Co first reported a position in SRPT in Q2 2020 and held it in 14 quarters. The position peaked at $994K in Q4 2021. 414 funds tracked by Wall St. Rank hold SRPT as of Q1 2024.

  • Bank Julius Baer & Co reported no remaining Sarepta Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Bank Julius Baer & Co sold 170 Sarepta Therapeutics shares in Q1 2024, an estimated $16.4K.
  • Bank Julius Baer & Co first reported a position in Sarepta Therapeutics in Q2 2020 and held it in 14 quarters.
  • Bank Julius Baer & Co's Sarepta Therapeutics position peaked at $994K in Q4 2021.
  • 414 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2024.

Based on Bank Julius Baer & Co's 13F filing for Q1 2024, filed 14 May 2024.